Skip to footer Insmed My WordPress Blog MENU INVESTORS / NEWS RELEASES News Releases IN THIS SECTION Select page... Investor Relations Events & Presentations Stock Information News Releases SEC Filings Annual Reports Analyst Coverage Corporate Governance Email Alerts Investor FAQs YEAR All Years 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 KEYWORDS Go Advanced Search NOV 5, 2021 Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) NOV 3, 2021 Insmed To Participate in Three November Conferences OCT 28, 2021 Insmed Ranks No. 1 on Science's 2021 Top Biopharma Employers List OCT 28, 2021 Insmed Reports Third Quarter 2021 Financial Results and Provides Business Update OCT 14, 2021 Insmed to Host Third Quarter 2021 Financial Results Conference Call on Thursday, October 28, 2021 OCT 5, 2021 Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) SEP 3, 2021 Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) SEP 1, 2021 Insmed To Participate in Five September Conferences AUG 6, 2021 Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) AUG 5, 2021 Insmed Reports Second Quarter 2021 Financial Results and Provides Business Update Show 10 Open per page «123456789…61» Stay In The Loop Want to stay up to date on our news, events, and filings? Set up your email alerts. SIGN UP View the latest Insmed Investor Presentation here. DOWNLOAD Culture Mission & Vision Careers Responsibility Patients ARIKAYCE® PULMOVANCE® Liposomal Technology Resources Science Our Research Team Pipeline and Diseases Clinical Trials Investigator-Initiated Research About History Management Team Board of Directors Global Healthcare Compliance Partnerships Investors Events & Presentations Stock Information News Releases SEC Filings Annual Reports Analyst Coverage Corporate Governance Email Alerts Investor FAQs Contact Us Insmed Incorporated © 2021 All rights reserved. Terms of UsePrivacy Policy Contact Us Culture Mission & Vision Careers Responsibility Patients ARIKAYCE® PULMOVANCE® Liposomal Technology Resources Science Our Research Team Pipeline and Diseases Clinical Trials Investigator-Initiated Research About History Management Team Board of Directors Global Healthcare Compliance Partnerships Investors Events & Presentations Stock Information News Releases SEC Filings Annual Reports Analyst Coverage Corporate Governance Email Alerts Investor FAQs © Insmed 2021 All Rights Reserved.Terms of UsePrivacy Policy Effective January 1, 2021, we have modified our Privacy Policy. Please read these updated terms and take some time to understand them. This website, as well as certain third parties that provide content, other functionality, or services to this site, may use Internet technologies to collect information. These technologies include cookies, local stored objects, web beacons, and other means. By using this site, you consent to our use of such cookies and similar technologies. OK